 Features |
Welcome to
OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.
|
| Sponsors |
|
| Links |
CDE-Directory - A Comprehensive Guide to Continuing Dental Education
OsseoNews - The World of Implant Dentistry Online
PalmDMD - PDA's in clinical dentistry
Medgadget - Emerging Medical Technologies
PalmDDS - PDA's in clinical dentistry
CurrentJournals - Keeping you updated Automatically - Keywords, Journals, Authors delivered weekly in an easy to read PDF format
|
|
US ban on Biora Products costs Straumann 10 million Swiss Francs |
Posted by:Editor
on Monday June 11th, 2007
|
The continuing FDA ban on importation of Biora`s Emdogain and Bone Substitute has cost parent company Straumann 10 million Swiss francs (8.14 million US$). Straumann chief executive Gilbert Achermann described the loss as `painful`. He furthermore stated that `The US FDA will reinspect our facility in Malmo, but we are not in a position to say when this will happen, If all goes well`, Biora products `could be reintroduced in the US in the first quarter of this year,` Additionally, `According to Achermann, the resumption of the company`s exports to the US depends on the results of an ongoing investigation by US authorities which could last several months.`
More
<<< Back  E-Mail This Topic: Dental Implant Industry
|
|
 |
! There are no comments posted for this item yet.
| |
